Last reviewed · How we verify

NCT05624333: VD2O

Vegan Diets: the Short-term Effects on Daily Muscle Protein Synthesis Rates as Compared to Omnivorous Diets in Older Adults Assessed by D2O.

Completed NA Last updated 24 March 2023
What this trial tests

NA trial testing Vegan diet (intervention) in Sarcopenia in 38 participants. Completed in 13 February 2023.

Timeline
9 January 2023
Primary endpoint
13 February 2023
13 February 2023

Quick facts

Lead sponsorWageningen University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposesupportive care
Enrollment38
Start date9 January 2023
Primary completion13 February 2023
Estimated completion13 February 2023
Sites1 location across Netherlands

Drugs / interventions tested

Conditions studied

Sponsor

Wageningen University

Who can join

Adults 65 to 79, any sex, with Sarcopenia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Consumers are increasingly encouraged to consume more plant-based foods and lower their consumption of foods from animal origin. However, the consequences of such a transition on muscle mass still remains to be explored. This is of particular importance in the older population, where sarcopenia is highly prevalent. The aim of this randomized controlled cross-over study is to investigate the short-term effect of a 10-day controlled vegan diet on daily muscle fractional synthesis rates in comparison to a 10-day controlled omnivorous diet in 35 community-dwelling older adults. Participants will follow a fully controlled vegan diet, directly followed by a fully controlled omnivorous diet for 10 days, or vice versa. Researchers will compare the effect of the vegan diet to the effect of the omnivorous diet.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. A Well-Balanced Vegan Diet Does not Compromise Daily Mixed Muscle Protein Synthesis Rates when Compared with an Omnivorous Diet in Active Older Adults: A Randomized Controlled Cross-Over Trial.
    Domić J, Pinckaers PJ, Grootswagers P, Siebelink E, et al · · 2025 · cited 9× · PMID 39732437 · DOI 10.1016/j.tjnut.2024.12.019

Verify or expand the search:

Other recruiting trials for Sarcopenia

Currently open trials in the same condition.

Other Wageningen University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05624333.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing